Halsa Pharma Private Limited
About Halsa Pharma Private Limited
Data last updated:
Halsa Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 February 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2003PTC138991.
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Sadhana Manmohan Damani and Kailashchandra Jasraj Purohit.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 201 – 2 Floor – 2 Plot – 208 Regent Chambers Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address201 – 2 Floor – 2 Plot – 208 Regent Chambers Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Halsa Pharma Private Limited FY 2025 filings available
Financial Statement Summary of Halsa Pharma Private Limited
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Halsa Pharma Private Limited
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Halsa Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Halsa Pharma Private Limited
Halsa Pharma Private Limited is audited by SAMRIA & CO for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SAMRIA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Halsa Pharma Private Limited
Halsa Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sadhana Manmohan Damani | Director | 16 May 2019 | 7 Years 4 Months | Current |
| Kailashchandra Jasraj Purohit | Director | 30 Jan 2019 | 7 Years 8 Months | Current |
| Mahesh Hemchand Purohit Also directs: Lollapalooza Enterprises LLP, Stenos Developers Private Limited, H J Realtech Private Limited and 1 more | Director | 16 May 2019 | 7 Years 4 Months | Current |
Ownership and Shareholding of Halsa Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Halsa Pharma Private Limited
Halsa Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Halsa Pharma Private Limited
Employment history and EPFO contributions of people linked to Halsa Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Halsa Pharma Private Limited
Halsa Pharma Private Limited has 8 board changes on record since 2019: 3 appointments and 5 cessations. The latest: Satyanarayan Radhakishan Vyas ceased to be Director on 04 Nov 2020.
Credit Ratings, Litigation & Regulatory Alerts for Halsa Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Halsa Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Halsa Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Halsa Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Halsa Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Halsa Pharma Private Limited
Halsa Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 February 2003 (23+ years old) and is registered under CIN U24230MH2003PTC138991.
Halsa Pharma has 3 current directors:
- Sadhana Manmohan Damani - Director
- Kailashchandra Jasraj Purohit - Director
- Mahesh Hemchand Purohit - Director
The CIN (Corporate Identification Number) of Halsa Pharma is U24230MH2003PTC138991. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Halsa Pharma was incorporated on 04 February 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
Satyanarayan Radhakishan Vyas ceased to be Director on 04 Nov 2020. Kailashchandra Jasraj Purohit ceased to be Additional Director on 30 Sep 2019. Mahesh Hemchand Purohit ceased to be Additional Director on 30 Sep 2019. Halsa Pharma has 8 board changes on record in total.
The registered office of Halsa Pharma is at 201 – 2 Floor – 2 Plot – 208 Regent Chambers Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021.
Halsa Pharma has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹4 Lakh.
Halsa Pharma operates in the pharma industry, in the drug formulation and development segment.
No. Halsa Pharma is not listed on any stock exchange. It is an unlisted company.
The compliance status of Halsa Pharma is compliant as of 14 August 2026. The company is actively filing with the Registrar of Companies.